You are on page 1of 5

Company Name

Ipca Laboratories Ltd.

Cipla Ltd.

Cadila Healthcare Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Ranbaxy Laboratories Ltd.

year

Debt-equity Ratio
2007
2008
2009
2010
2011
2007
2008
2009
2010
2011
2007
2008
2009
2010
2011
2007
2008
2009
2010
2011
2007
2008
2009
2010
2011

0.49
0.58
0.71
0.52
0.5
0.04
0.14
0.22
0.01
0.07
0.51
0.7
0.67
0.37
0.27
0
0
0
0.27
0.26
1.35
1.38
1.1
0.89
0.84

ROCE
16.73
14.43
16.22
17.51
18.02
25.33
20
19.05
18.87
15.25
13.98
13.42
16.32
19.66
18.83
32.85
28.83
40.54
30.31
30.97
9.46
9.54
-20.16
6.7
14.51

Total Asset
776.19
1018.07
1154.4
1408.16
1665.4
4413.74
5733.21
7567.49
8444.22
9713.93
1442.7
1915.1
2178.6
2331.1
2773.2
3035.84
3516.28
4019.45
4441.01
5065.38
7096.87
7956.92
12013.47
11604.95
13934.73

Fixed Asset
506.12
573.82
758.66
872.56
978
1872.9
2434.91
3059.61
3579.68
4182.07
741.5
783.9
836.9
950.4
1036.6
265.3
275.16
295.11
313.56
330.13
2435.45
2588.91
2815.53
3026.19
3159.83

Tangibility
0.652056842
0.563635113
0.657189882
0.619645495
0.587246307
0.424334012
0.424702741
0.404309751
0.423920741
0.430522971
0.513966868
0.409325884
0.384145782
0.407704517
0.373792009
0.087389322
0.078253154
0.073420493
0.07060556
0.065173788
0.343172413
0.325365845
0.234364426
0.260767173
0.226759327

Quick Ratio
1.13
1.4
1.4
1.55
1.77
1.13
0.92
0.66
0.84
0.65
0.82
1.23
1.16
1.22
1.23
0.1
0.13
0.43
0.68
0.68
0.56
0.4
0.58
0.54
0.8

Control
46.22
46.22
46.22
46.05
46.05
36.8
36.8
36.8
36.8
36.8
74.79
74.79
74.79
74.79
74.79
50.67
50.67
50.67
50.67
50.67
63.82
63.79
63.77
63.75
63.68

Tax rate(%)
19.18
20.21
20.3
23.02
22.8
0
16.33
13.81
18.38
16.59
11.73
13.7
0
0
4.21
34.6
34.05
33.43
32.96
31.49
66.37
-200.38
132.42
39.77
0

SUMMARY OUTPUT
Regression Statistics
Multiple R
0.865040238
R Square
0.748294613
Adjusted R Square
0.644651219
Standard Error
0.243501832
Observations
25
ANOVA
Regression
Residual
Total

df
7
17
24

SS
2.996632581
1.007983419
4.004616

Intercept
ROCE
Total Asset
Fixed Asset
Tangibility
quick ratio
control
tax rate

Coefficients
0.236265755
-0.02193332
9.73159E-05
-0.00029217
1.057141736
-0.11440334
0.006515648
-0.00247672

Standard Error
0.635725957
0.008630997
5.0704E-05
0.00013502
0.846248141
0.219227124
0.005125145
0.001098341

MS
F
0.428090369 7.219897
0.059293142

t Stat
0.371647173
-2.541227037
1.919296138
-2.163906682
1.249210114
-0.521848456
1.271309829
-2.254959672

P-value
0.714747
0.021087
0.071893
0.045001
0.228516
0.608509
0.220738
0.037611

Significance F
0.000430813

Lower 95%
-1.10499876
-0.040143135
-9.66009E-06
-0.000577037
-0.728285758
-0.576932133
-0.004297464
-0.004794012

Upper 95%
1.57753027
-0.00372351
0.00020429
-7.3034E-06
2.84256923
0.34812546
0.01732876
-0.00015942

Lower 95.0% Upper 95.0%


-1.10499876
1.57753027
-0.040143135 -0.003723511
-9.66009E-06 0.000204292
-0.000577037 -7.30337E-06
-0.728285758
2.84256923
-0.576932133 0.348125461
-0.004297464 0.017328759
-0.004794012 -0.000159418

You might also like